Status:
UNKNOWN
Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Poor Ovarian Response
Eligibility:
FEMALE
18-44 years
Phase:
PHASE2
PHASE3
Brief Summary
The management of poor ovarian responders (POR) remains the most challenging in In-Vitro Fertilization (IVF). The incidence of POR ranges between 9 and 24% (Caprio F, et al, 2015). POR refers to a re...
Detailed Description
The management of poor ovarian responders (POR) remains the most challenging in In-Vitro Fertilization (IVF). The incidence of POR ranges between 9 and 24% (Caprio F, et al, 2015). POR refers to a re...
Eligibility Criteria
Inclusion
- Age: 18-44 years at the time of interview
- POR patients defined as: AMH\<1.5 ng/nl, AFC of 7 or less, 5 oocytes or less retrieved in a previous cycle
- Patients undergoing controlled ovarian stimulation for any indication:
- Male factor
- Female factor
Exclusion
- Patients with diabetes, thyroid dysfunction
- Patients with abnormal uterine cavity
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT04273256
Start Date
February 11 2020
End Date
February 1 2023
Last Update
February 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon